# Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD

> **NCT05523648** · EARLY_PHASE1 · COMPLETED · sponsor: **Sichuan Leshan Traditional Chinese Medicine Hospital** · enrollment: 92 (actual)

## Conditions studied

- Chronic Hepatitis B
- Nonalcoholic Fatty Liver Disease

## Interventions

- **DRUG:** Chronic Hepatitis B

## Key facts

- **NCT ID:** NCT05523648
- **Lead sponsor:** Sichuan Leshan Traditional Chinese Medicine Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-05
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-21
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523648, "Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05523648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*